Brief: Hemostemix Announces Enrollment Milestone In The Acp-01 Phase Ii Critical Limb Ischemia Clinical Trial
09/04/2019 13:38
April 9 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX ANNOUNCES ENROLLMENT MILESTONE IN THE ACP-01
PHASE II
CRITICAL LIMB ISCHEMIA CLINICAL TRIAL
* HEMOSTEMIX INC - REACHED AN ENROLLMENT MILESTONE IN ITS
CONTINUING PHASE II CLINICAL TRIAL FOR CRITICAL LIMB ISCHEMIA
* HEMOSTEMIX INC - ENROLLMENT RATES HAVE INCREASED
SUBSTANTIALLY
OVER PAST SEVERAL WEEKS, WITH AN ADDITIONAL 9 PATIENTS ENROLLED
Source text for Eikon: ID:nGNXbTWTfJ
Further company coverage: HEM.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update